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AQP9

:   aquaporin 9

AUC

:   area under the curve

CEBPD

:   CCAAT/enhancer binding protein delta

CX3CR1

:   C‐X3‐C motif chemokine receptor 1

DEGs

:   differentially expressed genes

FASLG

:   fas ligand

FDR

:   false discovery rate

GEO

:   gene expression omnibus

GO

:   gene ontology

GRB2

:   growth factor receptor bound protein 2

HCM

:   hypertrophic cardiomyopathy

HSPA6

:   heat shock protein family A (Hsp70) member 6

IRS2

:   insulin receptor substrate 2

KEGG

:   kyoto encyclopedia of genes genomes

LAT2

:   linker for activation of T cells family member 2

LIMS1

:   LIM zinc finger domain containing 1

MAPKAPK2

:   mitogen‐activated protein kinase‐activated protein kinase 2

MI

:   myocardial infarction

PPI

:   protein--protein interaction

qRT‐PCR

:   quantitative RT‐PCR

ROC

:   receiver operating characteristic

TFEB

:   transcription factor EB

TPM3

:   tropomyosin 3

Myocardial infarction (MI) is the multifactorial injurious event, which involves all the components of the cardiac myocyte [1](#feb412423-bib-0001){ref-type="ref"}. The partial or complete occlusion of a coronary artery is the cause of MI, which leads to apoptosis and necrosis in the myocardium. It is reported that smoking, hypertension, diabetes mellitus, hypercholesterolemia, or dyslipidemia are the main causal factors of MI [2](#feb412423-bib-0002){ref-type="ref"}. Atherosclerosis also leads to MI [3](#feb412423-bib-0003){ref-type="ref"}. Even though survival rates after MI have been remarkably improved by early revascularization therapy and drug treatment, a significant number of patients develop heart failure [4](#feb412423-bib-0004){ref-type="ref"}. Despite significant advances in understanding of the causes of and treatment of MI in recent years, morbidity and mortality is still high [5](#feb412423-bib-0005){ref-type="ref"}.

miRNA are small, noncoding RNA that regulate the expression of target genes at the post‐transcription level. miRNA can modulate important complex gene regulatory pathways involved in cardiovascular development [6](#feb412423-bib-0006){ref-type="ref"}, [7](#feb412423-bib-0007){ref-type="ref"}, [8](#feb412423-bib-0008){ref-type="ref"}. More and more evidence reveals that signature expression pattern of miRNA plays a vital role in MI, cardiac arrhythmia, and pathological cardiac hypertrophy [9](#feb412423-bib-0009){ref-type="ref"}. It is noted that some miRNA expressed in heart are remarkably deregulated in patients with acute MI compared with healthy controls [10](#feb412423-bib-0010){ref-type="ref"}, [11](#feb412423-bib-0011){ref-type="ref"}. It is found that several miRNA including miR‐1, miR‐21, miR‐206, and miR‐499‐5p are deregulated in MI [12](#feb412423-bib-0012){ref-type="ref"}, [13](#feb412423-bib-0013){ref-type="ref"}, [14](#feb412423-bib-0014){ref-type="ref"}. Clinically, myoglobin, cardiac troponins, N‐terminal probrain natriuretic peptide, creatine kinases, and lactate dehydrogenase have been considered as diagnosis biomarkers of patients with acute MI [15](#feb412423-bib-0015){ref-type="ref"}, [16](#feb412423-bib-0016){ref-type="ref"}, [17](#feb412423-bib-0017){ref-type="ref"}, [18](#feb412423-bib-0018){ref-type="ref"}. It is worth mentioning that several miRNA including miR‐1, miR‐208α, miR‐126, miR‐122‐5p, and miR‐19a have been recognized as novel biomarkers for early diagnosis of acute MI [19](#feb412423-bib-0019){ref-type="ref"}, [20](#feb412423-bib-0020){ref-type="ref"}, [21](#feb412423-bib-0021){ref-type="ref"}, [22](#feb412423-bib-0022){ref-type="ref"}. Therefore, improving knowledge about the interaction between miRNA and target genes may be helpful in finding new pathological mechanism and markers for MI.

In this study, we aimed to find differentially expressed miRNA and genes in MI by integrated analysis. The miRNA‐gene target analysis was subsequently performed. Then, functional enrichment analysis including Gene Ontology (GO) and Kyoto Encyclopedia of Genes Genomes (KEGG) was used to investigate the biological function of genes followed by construction of a protein--protein interaction (PPI) network of top 100 differentially expressed genes (DEGs; 50 up‐regulated and 50 down‐regulated). Receiver operating characteristic (ROC) analysis was applied to analyze the diagnostic usefulness of identified differentially expressed miRNA and genes. Quantitative RT‐PCR (qRT‐PCR) was used to validate the result of the bioinformatics analysis. <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE29532> and <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE48060> datasets were used for expression and recovery analysis of DEGs. Our study may be helpful in understanding the pathogenic mechanism and finding valuable diagnosis biomarkers for MI.

Materials and methods {#feb412423-sec-0002}
=====================

Datasets {#feb412423-sec-0003}
--------

In this study, we searched datasets from the Gene Expression Omnibus (GEO) database (<http://www.ncbi.nlm.nih.gov/geo/>). The study type was characterized as 'expression profiling by array'. All selected datasets were genome‐wide expression data of mRNA/miRNA from MI group and normal group blood samples. And those standardized or primary datasets were included in this study. Finally, a total of three mRNA datasets (<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE34198>, <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE48060>, and <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61145>) and two miRNA datasets (<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31568> and <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61741>) were screened, which was shown in Table [1](#feb412423-tbl-0001){ref-type="table-wrap"}.

###### 

The mRNA and miRNA datasets

  GEO accession                                                                Platform                                                                Samples (N : P)   Country
  -------------------------------------------------------------- ------------- ----------------------------------------------------------------------- ----------------- ----------------
  <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE34198>   mRNA‐array    GPL6102 Illumina human‐6 v2.0 expression beadchip                       48 : 45           Czech Republic
  <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE48060>   mRNA‐array    GPL570 \[HG‐U133_Plus_2\] Affymetrix Human Genome U133 Plus 2.0 Array   21 : 31           USA
  <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61145>   mRNA‐array    GPL6106 Sentrix Human‐6 v2 Expression BeadChip                          10 : 7            South Korea
  <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31568>   miRNA‐array   GPL9040 febit Homo Sapiens miRBase 13.0                                 70 : 20           Germany
  <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61741>   miRNA‐array   GPL9040 febit Homo Sapiens miRBase 13.0                                 94 : 62           Germany

N, normal; P, patients.
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Identification of differentially expressed genes and differentially expressed miRNA {#feb412423-sec-0004}
-----------------------------------------------------------------------------------

With numbers of publicly available microarray databases, there will be an interest in combining data from different platforms. It is noted that metaMA package allows this integration of different platforms as it can handle missing data and eliminate the batch effects [23](#feb412423-bib-0023){ref-type="ref"}. In this study, Limma and metaMA packages were used to identify the DEGs. The normal inverse method was used to combine the *P* value in metaMA. The false discovery rate (FDR) was performed for multiple testing corrections of raw *P* value through the Benjamin and Hochberg method [24](#feb412423-bib-0024){ref-type="ref"}, [25](#feb412423-bib-0025){ref-type="ref"}. The threshold of DEGs was set as FDR \< 0.05. FDR \< 0.05 & \|Combined.ES\|\> 0.8 was the threshold of identifying differentially expressed miRNA.

miRNA‐gene target analyses {#feb412423-sec-0005}
--------------------------

Identifying the target genes of miRNA is a crucial step in exploring the function of miRNA in specific tissues and cells. Herein, six miRNA‐target prediction tools (RNA22, miRanda, miRDB, miRWalk, PICTAR2, and Targetscan) were applied to predict the target DEGs of differentially expressed miRNA. The miRNA‐targets that were predicted by more than four algorithms or verified by experiment in miRWalk database were screened out. Then, the miRNA‐target regulatory network was constructed, which was visualized using Cytoscape Software [26](#feb412423-bib-0026){ref-type="ref"}.

Functional annotation analyses of miRNA‐target differentially expressed genes {#feb412423-sec-0006}
-----------------------------------------------------------------------------

To obtain the biological function and signaling pathways of miRNA‐target DEGs, the GeneCoDis3 (<http://genecodis.cnb.csic.es/analysis>) software was used for GO (<http://www.geneontology.org/>) annotation and KEGG (<http://www.genome>. jp/kegg/pathway.html) pathway enrichment analysis. The threshold of GO function and KEGG pathway of DEGs was all set as FDR \< 0.05.

Protein--protein interaction network construction {#feb412423-sec-0007}
-------------------------------------------------

It is useful for understanding the molecule mechanism of MI by studying the interactions between proteins. To gain insights into the interaction between proteins encoded by DEGs and other proteins, the database of BioGRID (<http://thebiogrid.org>) was used to retrieve the predicted interactions between top 100 proteins encoded by DEGs (50 up‐regulated and 50 down‐regulated) and other proteins. Then, PPI network was visualized by the Cytoscape Software (<http://cytoscape.org/>). A node in the PPI network denotes protein, and the edge denotes the interactions.

Receiver operating characteristic analyses {#feb412423-sec-0008}
------------------------------------------

Using pROC package in R language, we performed the receiver operating characteristic analyses to assess the diagnostic value of DEGs. The area under the curve (AUC) under binomial exact confidence interval was calculated, and the receiver operating characteristic curve was generated.

Validation of quantitative RT‐PCR {#feb412423-sec-0009}
---------------------------------

In this study, five patients diagnosed as MI and five normal individuals were enrolled in this study. Both MI and corresponding normal blood samples were obtained and immediately frozen in liquid nitrogen. All participating individuals provided informed consent with the approval of the ethics committee of our hospital.

Total RNA of fresh blood samples from MI patients and normal individuals was extracted using TRizol reagent (Invitrogen, Foster City, CA, USA) according to the manual instructions. SuperScript III Reverse Transcription Kit (Invitrogen) was used to synthesize the cDNA. qRT‐PCR was performed using SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) on Applied Biosystems 7500 (Applied Biosystems). GAPDH served as internal control for gene detection, and the relative expression of genes was calculated using the fold change equation.

Expression analyses in the early stage of myocardial infarction and recovery‐related analysis of differentially expressed genes {#feb412423-sec-0010}
-------------------------------------------------------------------------------------------------------------------------------

To analyze the expression of DEGs in the early stage (different blood collection time points, time 1, time 2, time 3, time 4, time 5, and time 6) of MI in the dataset of <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE29532> and further investigate the association between DEGs and MI recovery in the dataset of <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE48060>, 12 DEGs including transcription factor EB (TFEB), insulin receptor substrate 2 (IRS2), growth factor receptor bound protein 2 (GRB2), fas ligand (FASLG), LIM zinc finger domain containing 1 (LIMS1), C‐X3‐C motif chemokine receptor 1 (CX3CR1), heat shock protein family A (Hsp70) member 6 (HSPA6), tropomyosin 3 (TPM3), linker for activation of T cells family member 2 (LAT2), CCAAT/enhancer binding protein delta (CEBPD), aquaporin 9 (AQP9), and mitogen‐activated protein kinase‐activated protein kinase 2 (MAPKAPK2) were selected for analysis.

Results {#feb412423-sec-0011}
=======

Differentially expressed genes and differentially expressed miRNA analysis {#feb412423-sec-0012}
--------------------------------------------------------------------------

A total of 1007 DEGs were identified as the threshold of FDR \< 0.05, consisting of 564 up‐regulated and 443 down‐regulated genes. Top 10 up‐ and down‐regulated DEGs were presented in Table [2](#feb412423-tbl-0002){ref-type="table-wrap"}. The heat map of top 100 DEGs was shown in Fig. [1](#feb412423-fig-0001){ref-type="fig"}. All DEGs were listed in the Table [S1](#feb412423-sup-0001){ref-type="supplementary-material"}. In addition, a total of 38 differentially expressed miRNA including 14 up‐regulated and 24 down‐regulated miRNA. Top 10 up‐ and down‐regulated differentially expressed miRNA was listed in Table [3](#feb412423-tbl-0003){ref-type="table-wrap"}. Figure [2](#feb412423-fig-0002){ref-type="fig"} showed the heat map of all differentially expressed miRNA.

###### 

Top 10 up‐ and down‐regulated DEGs

  ID       Symbol    Combined.ES    *P* value   FDR           Up/Down
  -------- --------- -------------- ----------- ------------- ---------
  55350    VNN3      1.098788106    1.68E‐08    0.00015739    Up
  1912     PHC2      1.106042072    4.44E‐08    0.000207716   Up
  7942     TFEB      0.930874415    8.63E‐08    0.000269206   Up
  8291     DYSF      0.944578311    2.10E‐07    0.000393166   Up
  7462     LAT2      0.91656781     1.75E‐07    0.000393166   Up
  2137     EXTL3     0.978263843    9.75E‐07    0.000707473   Up
  1052     CEBPD     0.93852956     1.03E‐06    0.000707473   Up
  366      AQP9      0.920634347    7.99E‐07    0.000707473   Up
  89846    FGD3      0.86933981     1.06E‐06    0.000707473   Up
  10043    TOM1      0.811419165    1.01E‐06    0.000707473   Up
  54438    GFOD1     −0.857872809   2.85E‐07    0.000444736   Down
  81537    SGPP1     −0.925693388   4.02E‐07    0.000538047   Down
  356      FASLG     −0.898564987   4.97E‐07    0.000544713   Down
  130814   PQLC3     −0.888672951   5.24E‐07    0.000544713   Down
  22836    RHOBTB3   −0.763444842   3.05E‐06    0.001188091   Down
  3560     IL2RB     −0.890989888   3.60E‐06    0.001227364   Down
  1524     CX3CR1    −0.854049867   4.19E‐06    0.00126511    Down
  9788     MTSS1     −0.818619651   4.16E‐06    0.00126511    Down
  962      CD48      −0.925369052   4.83E‐06    0.001414235   Down
  51699    VPS29     −0.772616109   5.02E‐06    0.001422705   Down
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![Heat map of top 100 DEGs in MI. Diagram presents the result of a two‐way hierarchical clustering of top 100 DEGs and samples. The clustering is constructed using the complete‐linkage method together with the Euclidean distance. Each row represents a DEG and each column, a sample. DEGs clustering tree is shown on the right. The color scale illustrates the relative level of DEGs expression: purple, below the reference channel; green, higher than the reference.](FEB4-8-897-g001){#feb412423-fig-0001}

###### 

Top 10 up‐ and down‐regulated differentially expressed miRNA

  Symbol            Combined.ES    *P* value     FDR           Up/Down
  ----------------- -------------- ------------- ------------- ---------
  hsa‐miR‐375       0.964233114    3.81E‐11      3.23E‐08      Up
  hsa‐miR‐520c‐3p   0.928272928    2.90E‐10      8.18E‐08      Up
  hsa‐miR‐132\*     0.897286366    4.05E‐10      8.58E‐08      Up
  hsa‐miR‐204       0.906784899    5.45E‐10      9.24E‐08      Up
  hsa‐miR‐142‐3p    0.87693145     1.32E‐09      1.86E‐07      Up
  hsa‐miR‐29c\*     0.83581277     3.13E‐09      3.31E‐07      Up
  hsa‐miR‐1274b     0.803505509    1.26E‐08      9.72E‐07      Up
  hsa‐miR‐1258      1.030135467    1.23E‐07      6.49E‐06      Up
  hsa‐miR‐1468      0.965203705    5.28E‐05      0.000520325   Up
  hsa‐miR‐609       0.887322197    0.000406945   0.00271117    Up
  hsa‐miR‐200a      −0.927575354   2.63E‐10      8.18E‐08      Down
  hsa‐miR‐767‐5p    −0.871863499   1.94E‐09      2.35E‐07      Down
  hsa‐miR‐455‐3p    −0.838268201   7.37E‐09      6.94E‐07      Down
  hsa‐miR‐646       −0.836200084   8.52E‐09      7.22E‐07      Down
  hsa‐miR‐627       −0.800880075   3.77E‐08      2.46E‐06      Down
  hsa‐miR‐1245      −0.917431476   4.02E‐07      1.46E‐05      Down
  hsa‐miR‐515‐5p    −1.095131558   1.33E‐05      0.000176153   Down
  hsa‐miR‐519b‐5p   −0.893325033   1.36E‐05      0.000177605   Down
  hsa‐miR‐155\*     −0.921431507   7.49E‐05      0.000694016   Down
  hsa‐miR‐330‐3p    −0.968066113   0.000129252   0.001085202   Down
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![Heat map of all differentially expressed miRNA in MI. Diagram presents the result of a two‐way hierarchical clustering of all differentially expressed miRNA and samples. The clustering is constructed using the complete‐linkage method together with the Euclidean distance. Each row represents a miRNA and each column, a sample. The miRNA clustering tree is shown on the right. The color scale illustrates the relative level of miRNA expression: purple, below the reference channel; green, higher than the reference.](FEB4-8-897-g002){#feb412423-fig-0002}

miRNA‐target gene interactions {#feb412423-sec-0013}
------------------------------

A total of 1186 miRNA‐target pairs including 392 up‐regulated miRNA‐down‐regulated target pairs and 639 down‐regulated miRNA‐up‐regulated target pairs were obtained. Among which, 132 up‐regulated miRNA‐down‐regulated target pairs and 113 down‐regulated miRNA‐up‐regulated target pairs have been confirmed by miRWalk. The MI‐specific miRNA‐target interaction network was shown in Fig. [3](#feb412423-fig-0003){ref-type="fig"}. Table [4](#feb412423-tbl-0004){ref-type="table-wrap"} listed the target DEGs of differentially expressed miRNA.

![Interaction networks of miRNA and target DEGs in MI. (A) Up‐regulated miRNA and target genes; (B) the down‐regulated miRNA and target genes. The rhombus and ellipses represent the miRNA and target DEGs, respectively. The red and green colors represent up‐regulation and down‐regulation, respectively. Ellipses with blue and black border represent top 10 up‐regulation and down‐regulation, respectively.](FEB4-8-897-g003){#feb412423-fig-0003}

###### 

The target DEGs of differentially expressed miRNA

  miRNA             Up/Down   Count   Target mRNA
  ----------------- --------- ------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  hsa‐miR‐302d      Up        75      PIGK, DNM1L, CDK6, LANCL1, FAM3C, AKAP11, CHN2, SH2D1B, SOCS4, SLC30A7, SPRED1, ELK4, ETFA, ENPP4, TNIK, METAP1, ATP6V0A2, GALK2, ZZZ3, ATP2C1, GLO1, DPY19L4, GUCY1A3, UBQLN1, FASLG, ITGB1, SMAD5, NAP1L1, NKTR, ARHGEF3, AK3, PBX3, PLAC8, PLAGL2, BRWD1, POLE3, NDFIP2, OTUD4, BCAP29, PTGDR, CYP20A1, PTGS1, HEG1, RPL15, RPL22, TRAPPC2, CREB3L2, SNTB1, TSPYL1, WEE1, ANKRD13C, KCTD10, LDOC1L, SDPR, DYRK2, PAQR8, AGPS, CGGBP1, RUNX3, ST3GAL5, FUBP1, RABEP1, TOMM20, TOMM70A, CLCN3, SPCS1, GTF2H3, RHOC, ISOC1, TSR1, CCL5, TXK, EIF2B2, BUB3, SCRN1
  hsa‐miR‐27a       Up        71      PIGK, ARL4C, CDK6, YWHAQ, ZHX1, CLCN3, SOCS4, WDR36, SLC30A7, CX3CR1, DUSP5, EIF5, GPR114, TNIK, LPIN1, DDHD2, MMD, ARL2BP, LETMD1, TMEM87A, ZZZ3, GCH1, STK39, DPY19L4, GRSF1, APEX1, INPP1, SMAD5, MAN2A1, MTR, NDUFS4, NKTR, PAFAH2, CRBN, PF4V1, PLAGL2, BRWD1, PPAT, RCBTB1, TMEM126B, TMEM9B, BBX, PCNP, PTGDR, HEG1, COG6, MS4A7, RAP2A, BCL2, CREB3L2, TSPYL1, WEE1, YES1, ZNF22, SEH1L, CANX, SH3BGRL2, TMTC4, AGPS, CBFB, ST3GAL5, FUBP3, BUB3, ZMYM4, GOSR2, IFNG, LFNG, OTUD4, AASDHPPT, RPL19, DERL1
  hsa‐miR‐520c‐3p   Up        70      DNM1L, UST, ARL4C, CDK6, GBP4, GNPDA2, WDR36, SLC30A7, SRFBP1, SPRED1, ELK4, F2R, ALDH3A2, METAP1, LPIN1, SLC35A3, GALK2, ATP5S, GLO1, DPY19L4, GTF2H3, GUCY1A3, FASLG, KLRD1, RHOC, LIMS1, SMAD5, PAFAH2, ARHGEF3, PBX3, BFAR, PLAC8, NIP7, PLAGL2, BRWD1, MTMR12, LEPROT, LAX1, CHCHD3, RNF125, PLCXD1, SMPD3, TSR1, BCAP29, KIAA1191, PTGDR, CYP20A1, PTGS1, HEG1, SLAMF7, MS4A7, CCL5, TRAPPC2, SUSD1, PHACTR4, TBCA, WEE1, MYCT1, LRCH3, AGPS, RUNX3, CDC23, PER2, TMEM41A, RABEP1, TRAM2, CLCN3, SPCS1, TXK, EIF2B2
  hsa‐miR‐302b      Up        69      DNM1L, CDK6, LANCL1, AKAP11, CHN2, SH2D1B, SOCS4, SLC30A7, SPRED1, ELK4, ETFA, ENPP4, TNIK, GPD1L, METAP1, ATP6V0A2, GALK2, ATP2C1, KLHL20, GUCY1A3, UBQLN1, FASLG, ITGB1, NAP1L1, NKTR, ARHGEF3, AK3, PBX3, PLAC8, PLAGL2, BRWD1, POLE3, NDFIP2, OTUD4, DOCK10, BCAP29, PTGDR, CYP20A1, RPL15, RPL22, TRAPPC2, CREB3L2, SNTB1, TSPYL1, WEE1, ANKRD13C, KCTD10, LDOC1L, SDPR, DYRK2, PAQR8, AGPS, CGGBP1, RUNX3, ST3GAL5, RABEP1, TOMM70A, CLCN3, GLO1, SPCS1, GTF2H3, RHOC, ISOC1, TSR1, CCL5, TXK, EIF2B2, BUB3, SCRN1
  hsa‐miR‐646       Down      61      TRIB1, ADAR, TXNIP, CAMKK2, RALBP1, LMAN2, RNF24, KLHL2, B3GNTL1, MARK2, TPCN2, KCTD2, GABARAPL1, FBXO33, RASSF3, HAL, NDST1, RAB43, IFRD1, IL1R1, INPP5A, INPP5D, MEFV, MAP3K3, MYD88, NFYC, NOV, ACOX1, RAPGEFL1, PFKFB3, PITPNA, TMEM127, TBC1D14, RAF1, RALB, ST3GAL2, SLC6A6, SLC9A1, SLC19A1, SOD2, SP1, STAT3, SVIL, SYK, TOP3A, TPM3, LAPTM5, KIAA0319L, DNAJC5, KREMEN1, KLF7, IRS2, MTMR3, ENTPD1, PPM1F, ARHGEF11, GAB2, SMG7, OSCAR, GPR27, SLC2A3
  hsa‐miR‐1291      Down      59      MRVI1, SLC43A2, DBN1, MARK2, EXTL3, SLC9A8, DNAJB5, GALNS, CECR6, ANPEP, RAB43, IL1RN, MYBPH, NINJ1, NOTCH1, FURIN, PAK2, GMIP, PFKFB4, POR, ASF1B, MAPK3, PTAFR, PREX1, PTPN6, RAF1, RPS6KA1, ABHD4, LPPR2, SLC9A1, SLC11A1, SP1, STAT5B, SYK, TBL1X, TKT, TLE3, TNFRSF1B, TRIM25, LAPTM5, TREML2, UBTD1, ABTB1, LIMD2, STK40, KREMEN1, ZNF341, VNN2, REPS2, MAPKAPK2, SFXN5, ENTPD1, H2AFY, PPM1F, TBKBP1, PLEKHM1, IQSEC1, OSCAR, PFKFB3
  hsa‐miR‐204       Up        54      PDCD6IP, DNM1L, ARL4C, LANCL1, HMG20A, CHN2, SOCS4, SLC30A7, PPM1K, SPRED1, ELK4, F2R, RHOBTB3, GPD1L, METAP1, DDHD2, TMEM87A, ZNF451, MLH3, SBK1, PAFAH2, AK3, BRWD1, PRMT6, SMPD3, CNDP2, BCAP29, THAP11, PTGDR, CYP20A1, PTGS1, SLAMF7, RBM3, BCL2, CREB3L2, SPATS2, UBP1, WEE1, ZNF22, MYCT1, EOMES, LDOC1L, PAQR8, AGPS, ST3GAL5, SCRN1, TOMM70A, POP4, ZNF689, SFT2D2, ALDH6A1, PDHA1, CHCHD3, CDC23
  hsa‐miR‐330‐3p    Down      52      FRAT1, TRIB1, ST6GALNAC2, IRAK3, AKAP13, RNF24, FCHO2, JDP2, CPD, GLT1D1, PTK2B, WDFY3, SMG5, CECR6, AQP9, LAMP2, MXD1, MSRA, ACOX1, PFKFB3, SERPINA1, RNF130, PPM1H, TBC1D14, CXCL16, RRAGD, RAF1, RALB, RXRA, ABHD4, ST3GAL2, SOD2, TBL1X, TXNRD1, TRIM25, TFEB, PPP1R3B, STEAP4, DOCK5, DNAJC5, CRISPLD2, KREMEN1, ULK1, SSH2, MTMR3, VAPA, ENTPD1, ZNF516, KIAA0232, SMG7, RBM23, SP1
  hsa‐miR‐200a      Down      46      CD2BP2, OSCAR, CPD, CSTA, FKBP5, WDFY3, GRB2, LBR, CYP4F3, MAK, MAP3K3, NDUFB3, NUP98, FURIN, ACOX1, PITPNA, PPP2R2A, PRKAB1, MCTP2, PPM1H, SIPA1L2, RALB, MAP2K4, SLC6A6, SP1, STAT5B, THBD, TOP3A, LAT2, DNAJC5, SH3BP5L, KLF7, IRS2, REPS2, CD163, ENTPD1, RAB3D, ZNF516, KIAA0319, FCHO2, CYP1B1, OTX1, RGL2, SOD2, STXBP2, RASSF2
  hsa‐miR‐515‐5p    Down      46      IRAK3, EPHB4, ERF, CHSY1, FKBP5, FOSL2, TMEM2, ZDHHC5, GDI1, RASSF3, APLP2, IL1R1, RERE, PAK2, ACOX1, PHF21A, PITPNA, PPP2R2A, TMEM127, PPM1H, RAC2, RNASE6, SLC11A1, SP1, STAT5B, THBD, TPM3, TUFT1, PPP1R3B, LIMD2, ELL, CASP9, FBXL20, ARHGAP19, SSH2, KLF7, MTMR3, CADPS2, ENTPD1, RASSF2, USP3, DGCR2, VAV3, CD55, DAPK2, NOTCH1
  hsa‐miR‐1912      Down      46      ADAR, MRVI1, ATG7, IRAK3, GLT1D1, FLOT2, SLC9A8, KCTD2, FOSL2, SNX11, RAB43, IFRD1, AQP9, MYBPH, MYD88, NUP98, RAPGEFL1, PFKFB3, TREM1, PRKAB1, TMEM127, MCTP2, NSFL1C, PELI2, ZNFX1, SLA, SLC2A3, SLC6A6, SLC11A1, SRPK1, STAT5B, SYK, TGFA, TKT, TPM3, MLF2, SH3BP5L, CFLAR, VAPA, LITAF, ENTPD1, RAB3D, ABCG1, TBKBP1, ACTN4, ZDHHC18
  hsa‐miR‐508‐5p    Down      42      RASGRP4, AMICA1, JDP2, CR1, GLT1D1, CYP1B1, FKBP5, LAMP2, LCP1, MEFV, RERE, PAK2, ACOX1, PIK3CD, PPP2R3A, PTAFR, PROK2, ZFAND3, SLC11A1, SULT1A2, SULT1A1, TBL1X, TFE3, TPM3, TUFT1, LAT2, TRIM25, TREML2, ARHGAP19, CFLAR, SFXN5, DGCR2, OSCAR, NARF, SIGLEC9, HSPA6, SSH3, RBM23, FBXL20, SSH2, ENTPD1, RAB3D
  hsa‐miR‐455‐3p    Down      40      RNF24, EXTL3, UBN1, LAMP2, RERE, PAK2, FAM53C, PFKFB4, PPP1R10, PPP2R2A, TMEM127, SLC45A4, PTAFR, SLC22A4, SRPK1, SVIL, TGFA, SNX27, KLF7, SOCS3, ZBED1, SFXN5, KIAA0319, CEBPD, TXNIP, CKAP4, SCRG1, FKBP5, PSD4, NARF, SIGLEC9, GNAI2, HSPA6, IFNAR1, ACOX1, CXCL16, TFE3, TPM3, BCL2L12, USP10
  hsa‐miR‐450b‐5p   Down      40      MRVI1, CAP1, RALBP1, EPHB1, ETS2, CECR6, HMGB2, CLEC4D, RAB43, LAMP2, LBR, PAK2, CKLF, C1RL, PIK3CD, PPP2R2A, PPP3CA, PELI1, KLHL8, RAC2, ST3GAL2, SOD2, STAT5B, TPM3, C5AR1, STEAP4, KIAA0319L, SNX27, SSH2, KLF7, IRS2, ADAM19, USP10, VAPA, B4GALT5, ENTPD1, ZNF516, IQSEC1, SLC43A2, PYCARD
  hsa‐miR‐520d‐5p   Down      33      CDH2, TRIB1, TXNIP, CAMKK2, FCHO2, WDFY3, QPCT, MXD1, MAK, PAK2, PHF21A, PFKFB3, PITPNA, RBM23, PRKAB1, RNASE6, SLC6A6, SRPK1, SUPT4H1, TBL1X, TTN, TUFT1, TRIM25, NDEL1, RAB3D, DGCR2, ADM, SYF2, LMNB1, PAK1, PROK2, SOD2, CRISPLD2
  hsa‐miR‐139‐5p    Down      33      ABCC5, MRVI1, FCHO2, JDP2, OSCAR, ECE1, CLEC5A, APLP2, MXD1, NIT1, NOTCH1, PAK2, ACOX1, PITPNA, PPP2R3A, SLC45A4, ZFAND3, SRPK1, TBL1X, THBD, TPM3, TRIM25, VPS37B, ITPKC, DNAJC5, CRISPLD2, ARHGAP19, SSH2, KLF7, ABCG1, KIAA0319, HMGB2, RHOT1
  hsa‐miR‐142‐3p    Up        30      MGLL, ANKRD46, SPRED1, RHOBTB3, MMD, HECTD1, KLHL20, DPY19L4, PLRG1, BRWD1, SIDT1, RHEB, RPE, DENND2D, CALM1, CUL5, GOSR2, PUM1, EIF5, GPD1L, SH2D1A, GOLT1B, OTUD4, DOCK10, KIAA1191, CREB3L2, SKP2, TSPYL1, YES1, YWHAH
  hsa‐miR‐375       Up        29      ARL4C, ELK4, MMD, LEPROT, ANKMY2, SLC25A15, FAM3C, CTSC, ANKRD46, SPRED1, DPY19L1, SLC35A3, ARL2BP, CKAP2, ITGB1, SFT2D2, PAFAH2, CMAS, KIAA1191, CYP20A1, RCN2, BCL2, C1QBP, UBE3A, CUL5, KCTD10, TMTC4, PAQR8, SLC7A6
  hsa‐miR‐767‐5p    Down      29      BASP1, CAMKK2, LTB4R, TMEM71, HEY1, NRG1, HLA‐C, MXD1, NCF4, NQO2, ACOX1, PIK3CD, PPP3CA, AGTRAP, MAP2K4, TGFA, TPM3, LAT2, SSH2, CFLAR, TMEM88, VAPA, B4GALT5, SFXN5, BRE, ZNF516, LRPAP1, TLE3, RAB3D
  hsa‐miR‐627       Down      29      IRAK3, PADI2, ZNF467, GPX3, MYD88, RAPGEFL1, PFKFB4, PITPNA, SLC12A9, PTPN6, MAP2K4, SLA, TREML2, KREMEN1, MTMR3, BAIAP3, SFXN5, KIAA0232, CYP1B1, CD55, EPHB1, ALDOA, NINJ1, NOTCH1, TLR8, TREM1, PRKAB1, SP1, OGFRL1
  hsa‐miR‐217       Down      28      ATG7, IRAK3, FCGR2A, CHSY1, LBR, MXD1, ACOX1, PHKA2, TREM1, WWC3, PPM1H, SLC6A6, SLC2A11, STAT5B, TGFA, TPD52L2, DNAJC5, ARHGAP19, CFLAR, MTMR3, CADPS2, ENTPD1, RAB3D, PPM1F, KIAA0232, PLEKHM1, CKAP4, STK40
  hsa‐miR‐519b‐5p   Down      26      CAMKK2, IRAK3, FKBP5, WDFY3, SLC9A8, IFRD1, LAMP2, LCP1, LIMK2, PAK2, FAM53C, PHF21A, PIK3CD, PPP2R3A, PELI2, PTAFR, PPM1H, MAP2K4, MMP25, ST3GAL2, TLR2, RNF122, ARHGAP19, CFLAR, MTMR3, ENTPD1
  hsa‐miR‐508‐3p    Up        22      ARL4C, MPHOSPH9, WDR36, ELK4, DPY19L4, ITGA4, COMMD10, PPAT, PTGS1, RAP2A, RARS, RPE, RPL15, STAT1, UBP1, YWHAH, MYCT1, LPXN, ADAMTS1, FAM20B, MRPS21, PUM1
  hsa‐miR‐938       Down      19      TRIB1, ADAR, ADM, DEDD2, EPOR, CECR6, MXD1, NUP98, FAM53C, MAP2K4, LPPR2, SLC11A1, SLC19A1, SRPK1, DNAJC5, SSH2, ADAM19, CFLAR, VAV3
  hsa‐miR‐568       Down      18      CAP1, SEMA4B, LILRB3, FBXO33, GALNS, CLEC4D, MSRA, NOTCH1, PHF21A, TREM1, RHOT1, MCTP2, SLC6A6, STAT5B, WAS, PPP1R3B, STEAP4, ELL
  hsa‐miR‐488\*     Down      17      AKAP13, NDST1, ACOX1, PHF21A, PELI1, PPM1H, SYK, TFE3, TPM3, C5AR1, CNTNAP3, PAQR6, SNX27, CFLAR, RASSF2, BRMS1, RXRA
  hsa‐miR‐566       Down      17      IRAK3, RASGRP4, MAST3, MEFV, RAPGEFL1, AGTRAP, PTAFR, NADK, STAT3, TBL1X, TPM3, CRISPLD2, EXTL3, FOSL2, RRAGD, STXBP2, MGAM
  hsa‐miR‐1258      Up        14      SLC30A7, ENPP4, ATP6V0A2, ZNF451, ALDH6A1, NKTR, BRWD1, PSMC2, PSMD10, NRIP1, LRCH3, RUNX3, SCRN1, ANKRD46
  hsa‐miR‐1245      Down      14      CCR1, IFNAR1, NIT1, RHOT1, PTPN6, SLC2A11, SYK, TOP3A, LAT2, PPP1R3B, CRISPLD2, CFLAR, RASSF2, KIAA0232
  hsa‐miR‐31\*      Down      14      CAMKK2, CYP1B1, FKBP5, KCTD2, MYD88, SLC6A6, STAT3, TLE3, TRIM25, SNX27, KIAA0232, TXNIP, HSPA6, SP1
  hsa‐miR‐609       Up        13      UST, CDK6, CTSC, DPY19L4, GRSF1, MAX, MGAT2, CREB3L2, ARV1, TRAM2, ALDH6A1, PLAC8, ACP1
  hsa‐miR‐491‐3p    Down      10      FKBP5, NOV, PAK2, RHOT1, SLA, THBD, TPM3, SNX27, VAPA, SULT1B1
  hsa‐miR‐155\*     Down      9       IRAK3, FCHO2, RERE, NOTCH1, PITPNA, TRIM25, MRVI1, TXNIP, MYD88
  hsa‐miR‐1468      Up        7       SEH1L, SLC30A7, ENPP4, ZZZ3, GNPTAB, CALM1, TMEM41A
  hsa‐miR‐132\*     Up        3       BCL2, RPL15, ACRBP
  hsa‐miR‐487b      Down      1       MAP2K4
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Enrichment analyses of target genes of differentially expressed miRNA {#feb412423-sec-0014}
---------------------------------------------------------------------

In target genes analysis of differentially expressed miRNA, a total of 528 target DEGs were obtained. To study the biological function of these target DEGs, GO enrichment and KEGG pathway analysis were performed. Based on the top 15 GO terms, enrichment analysis (Fig. [4](#feb412423-fig-0004){ref-type="fig"}), carbohydrate metabolic process, platelet activation, and nerve growth factor receptor signaling pathway were the most significantly enriched biological processes; intracellular, nucleolus, and membrane fraction were the most remarkably enriched cellular components; hydrolase activity, sequence‐specific DNA binding transcription factor activity, and protein serine/threonine kinase activity were the most significantly enriched molecular functions. Additionally, hypertrophic cardiomyopathy (HCM) and viral myocarditis were the most remarkably enriched signal pathways (Table [5](#feb412423-tbl-0005){ref-type="table-wrap"} and Fig. [4](#feb412423-fig-0004){ref-type="fig"}).

![Top 15 significant enrichment GO and KEGG terms of DEGs. (A) BP: biological process; (B) CC: cellular component; (C) MF: molecular function; (D) KEGG: signaling pathway.](FEB4-8-897-g004){#feb412423-fig-0004}

###### 

Enriched KEGG pathway of target DEGs in MI

  Items   Items_Details                               Count   Size   FDR         Symbols
  ------- ------------------------------------------- ------- ------ ----------- ------------------------------------------------------------------------------------------------------------------------------------------
  04650   Natural killer cell‐mediated cytotoxicity   18      125    1.71E‐10    SH2D1B, MAPK3, PTK2B, RAC2, SH2D1A, IFNG, GRB2, SYK, HLA‐C, FASLG, PTPN6, PAK1, KLRD1, RAF1, PIK3CD, PPP3CA, IFNAR1, VAV3
  04666   Fc gamma R‐mediated phagocytosis            13      92     8.05E‐08    MAPK3, WAS, RAC2, SYK, GAB2, DNM1L, FCGR2A, PAK1, RAF1, PIK3CD, INPP5D, VAV3, LIMK2
  04662   B‐cell receptor signaling pathway           11      75     5.55E‐07    MAPK3, RAC2, GRB2, LILRB3, SYK, PTPN6, RAF1, PIK3CD, PPP3CA, INPP5D, VAV3
  05200   Pathways in cancer                          21      324    9.56E‐07    CDK6, STAT1, MAPK3, TGFA, MAX, RAC2, STAT3, TPM3, GRB2, RALB, CASP9, FASLG, RALBP1, SKP2, RAF1, PIK3CD, BCL2, ITGB1, RXRA, DAPK2, STAT5B
  04722   Neurotrophin signaling pathway              13      124    1.41E‐06    YWHAH, MAPK3, YWHAQ, MAPKAPK2, GRB2, MAP3K3, FASLG, RAF1, IRAK3, PIK3CD, BCL2, RPS6KA1, IRS2
  05152   Tuberculosis                                15      172    1.50E‐06    STAT1, MAPK3, TLR2, ATP6V0A2, IFNG, SYK, CASP9, MYD88, FCGR2A, RAF1, BCL2, PPP3CA, NFYC, LAMP2, CR1
  05162   Measles                                     13      130    2.02E‐06    CDK6, STAT1, TLR2, SH2D1A, STAT3, IFNG, HSPA6, MYD88, FASLG, PIK3CD, ADAR, STAT5B, IFNAR1
  04010   MAPK signaling pathway                      18      262    2.30E‐06    MAPK3, RASGRP4, MAX, IL1R1, RAC2, MAPKAPK2, GRB2, MAP3K3, MAP2K4, HSPA6, ELK4, FASLG, DUSP5, PAK1, RAF1, PPP3CA, RPS6KA1, PAK2
  05410   HCM                                         5       82     0.0278085   ITGA4, TTN, TPM3, ITGB1, PRKAB1
  05416   Viral myocarditis                           4       63     0.043939    CD55, RAC2, CASP9, HLA‐C
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Protein--protein interaction network {#feb412423-sec-0015}
------------------------------------

To obtain the interaction between the proteins encoded by DEGs and other proteins, PPI network was explored and visualize by Cytoscape. PPI networks of top 50 up‐regulated and top 50 down‐regulated DEGs were shown in Fig. [5](#feb412423-fig-0005){ref-type="fig"}. As Fig. [5](#feb412423-fig-0005){ref-type="fig"} shown, the network consisted of 170 nodes and 148 edges. The top twelve proteins with a high degree were GRB2 (degree = 8), PLAUR (degree = 8), FASLG (degree = 8), BCOR (degree = 7), TFEB (degree = 6), DDIT3 (degree = 6), IRS2 (degree = 6), MAST3 (degree = 5), DDX21 (degree = 5), IL2RB (degree = 5), LIMS1 (degree = 5), and FLOT1 (degree = 5).

![The PPI networks of top 100 DEGs. All the ellipses are proteins encoded by top 100 DEGs. The red and green colors represent up‐regulation and down‐regulation, respectively. Ellipses with blue and black border represent top 10 up‐regulation and down‐regulation, respectively.](FEB4-8-897-g005){#feb412423-fig-0005}

Receiver operating characteristic curve analysis {#feb412423-sec-0016}
------------------------------------------------

We performed receiver operating characteristic curve analyses and calculated the AUC to assess the discriminatory ability of selected six miRNA (miR‐27a, miR‐31\*, miR‐139‐5p, miR‐204, miR‐375, and miR‐1291) and three DEGs (CX3CR1, HSPA6, and TPM3) from GEO dataset (Fig. [6](#feb412423-fig-0006){ref-type="fig"}). The AUC of all these DEGs and miRNA was \> 0.7. MiR‐27a, miR‐31\*, and miR‐1291 had the largest AUC. For MI diagnosis, the specificity and sensitivity of miR‐27a were 72.9% and 95%, respectively; the specificity and sensitivity of miR‐31\* were 78.6% and 85%, respectively; the specificity and sensitivity of miR‐139‐5p were 84.3% and 65%, respectively; the specificity and sensitivity of miR‐204 were 77.1% and 75%, respectively; the specificity and sensitivity of miR‐375 were 88.6% and 65%, respectively; the specificity and sensitivity of miR‐1291 were 90% and 65%, respectively; the specificity and sensitivity of CX3CR1 were 96.8% and 52.4%, respectively; the specificity and sensitivity of HSPA6 were 67.7% and 81%, respectively; the specificity and sensitivity of TPM3 were 71% and 71.4%, respectively. In addition, the data of the receiver operating characteristic analysis including the C‐statistic and 95% confidence interval and odds ratio and 95% confidence interval were listed in Table [6](#feb412423-tbl-0006){ref-type="table-wrap"}.

![receiver operating characteristic curves of selected DEGs and differentially expressed miRNA between MI patients and healthy controls. (A) miR‐27a; (B) miR‐31\*; (C) miR‐1291; (D) miR‐139‐5p; (E) miR‐204; (F) miR‐375; (G) CX3CR1; (H) HSPA6; (I) TPM3. The receiver operating characteristic curves were used to show the diagnostic ability of these selected DEGs and differentially expressed miRNA with specificity and sensitivity. The *x*‐axis shows 1‐specificity, and *y*‐axis shows sensitivity.](FEB4-8-897-g006){#feb412423-fig-0006}

###### 

The data of receiver operating characteristic analysis

  miRNA/mRNA   AUC      95% confidence interval   Odds ratio   95% confidence interval
  ------------ -------- ------------------------- ------------ -------------------------
  miR‐27a      0.8754   0.7902--0.9605            51           6.3793--407.7280
  miR‐31\*     0.8575   0.7615--0.9535            20.7778      5.3666--80.4666
  miR‐1291     0.8393   0.7432--0.9354            16.7143      5.0049--55.8192
  miR‐139‐5p   0.7921   0.6707--0.9136            9.961        3.2439--30.5871
  miR‐204      0.7625   0.6457--0.8793            10.125       3.1877--32.1598
  miR‐375      0.7943   0.6725--0.9161            14.3929      4.4338--46.7221
  CX3CR1       0.7389   0.5844--0.8933            33           3.7729--288.6339
  HSPA6        0.7604   0.6221--0.8987            6.72         1.9153--23.5773
  TPM3         0.7189   0.578--0.8598             6.1111       1.7972--20.7800
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Quantitative RT‐PCR {#feb412423-sec-0017}
-------------------

To verify the bioinformatics analyses, the expression level of DEGs and differentially expressed miRNA was quantified by qRT‐PCR in five blood samples of MI patients and five normal blood samples. Three DEGs (HSPA6, CX3CR1, and TPM3) and three differentially expressed miRNA (miR‐139‐5p, miR‐31\*, and miR‐27a) were selected for validation. As showed in Fig. [7](#feb412423-fig-0007){ref-type="fig"}, HSPA6, miR‐139‐5p, miR‐31\*, and miR‐27a were up‐regulated and CX3CR1 and TPM3 were down‐regulated. The validation result was consistent with the bioinformatics except TPM3, miR‐139‐5p, and miR‐31\*.

![Validation differentially expressed miRNAs and genes in the MI blood by qRT‐PCR. (A) The expression of differentially expressed genes; (B) The expression of differentially expressed miRNAs.](FEB4-8-897-g007){#feb412423-fig-0007}

Early stage expression analyses and recovery‐related analysis of differentially expressed genes {#feb412423-sec-0018}
-----------------------------------------------------------------------------------------------

As shown in Fig. [8](#feb412423-fig-0008){ref-type="fig"}, TFEB, IRS2, GRB2, FASLG, LIMS1, CX3CR1, HSPA6, TPM3, LAT2, CEBPD, AQP9, and MAPKAPK2 were differentially expressed in different time points. Furthermore, all these genes were associated with the recovery of MI (Fig. [9](#feb412423-fig-0009){ref-type="fig"}).

![Expression of DEGs in early stage of MI. Time 1: 12 h after blood collection; Time 2: 24 h after blood collection; Time 3: 36 h after blood collection; Time 4: 72 h after blood collection; Time 5: 84 h after blood collection; Time 6: 96 h after blood collection.](FEB4-8-897-g008){#feb412423-fig-0008}

![Recovery‐related analysis of DEGs.](FEB4-8-897-g009){#feb412423-fig-0009}

Discussion {#feb412423-sec-0019}
==========

Myocardial infarction is an important clinical problem because of its large contribution to mortality. Therefore, it is urgent to elucidate MI carcinogenesis mechanism for developing novel diagnose that will be highly specific to malignant cells, with minimal or no risk of adverse effect. In this study, we found several differentially expressed miRNA and genes, which may play an important role in the development of MI.

Linker for activation of T cells family member 2 is involved in the process of calcium mobilization, which is associated with coronary artery calcification in atherosclerosis [27](#feb412423-bib-0027){ref-type="ref"}. Herein, we found that LAT2 was regulated by both miR‐767‐5p and miR‐1245 in the blood of MI. MiR‐767‐5p has been found differentially expressed in the heart tissue of patients with MI [11](#feb412423-bib-0011){ref-type="ref"}. However, there are not any reports about miR‐1245 in the development of heart. Further research is needed to study the function of miR‐1245.

CCAAT/enhancer binding protein delta (also called CELF) is a transcription factor important in activating the expression of inflammatory genes in cardiac myocytes [28](#feb412423-bib-0028){ref-type="ref"}. In animal models, the expression of CEBPD altered in skeletal and muscular functions and overexpression of the dominant negative CEBPD protein results in fibrosis, cardiac hypertrophy, and dilated cardiomyopathy [29](#feb412423-bib-0029){ref-type="ref"}, [30](#feb412423-bib-0030){ref-type="ref"}, [31](#feb412423-bib-0031){ref-type="ref"}. In our study, CEBPD was regulated by miR‐455‐3p in the blood of MI. It is noted that the expression of miR‐455‐3p was deregulated early during acute MI [32](#feb412423-bib-0032){ref-type="ref"}.

C‐X3‐C motif chemokine receptor 1 is associated with the prevalence of coronary heart disease or MI [33](#feb412423-bib-0033){ref-type="ref"}. In this study, we found that CX3CR1 was under the regulation of miR‐27a. Romaine *et al*. [34](#feb412423-bib-0034){ref-type="ref"} found that miR‐27a had a high specificity in predicting the occurrence of left ventricular failure 6 months after acute MI. It is worth mentioning that miR‐27a is the prognostic indicator for acute MI [35](#feb412423-bib-0035){ref-type="ref"}. In this study, we found that both miR‐27a and target gene CX3CR1 had a great diagnostic value for MI.

Aquaporin 9 is a gap junction network gene that is vital to heart function. It is reported that AQP9 is also related to acute MI [36](#feb412423-bib-0036){ref-type="ref"}. Kuiper *et al*. [37](#feb412423-bib-0037){ref-type="ref"} found that TFEB was expressed in the myocardium of the adult. In this study, we found that AQP9 and TFEB were under the regulation of miR‐330‐3p in blood of MI. It is noted that miR‐330‐3p is up‐regulated in heart but down‐regulated in the plasma of patients with chronic heart failure [38](#feb412423-bib-0038){ref-type="ref"}.

In addition, we also found several DEGs (such as IRS2, GRB2, FASLG, and LIMS1) with a high degree in the PPI network. IRS2 plays a key role in cardiac homeostasis regulation [39](#feb412423-bib-0039){ref-type="ref"}. Zawada *et al*. [40](#feb412423-bib-0040){ref-type="ref"} also found that GRB2 plays an important role in the signaling pathway for cardiac hypertrophy. Herein, we found both IRS2 and GRB2 were regulated by miR‐200a. It is demonstrated that miR‐200a is involved in the cardiovascular differentiation [41](#feb412423-bib-0041){ref-type="ref"}.

Fas ligand (also called TNFSF6) is a member of the TNF family and the main activator of the extrinsic apoptotic pathway that binds the TNF receptor to induce apoptosis during MI [42](#feb412423-bib-0042){ref-type="ref"}. LIMS1 (also called PINCH1) has been suggested to be associated with left‐sided congenital heart disease [43](#feb412423-bib-0043){ref-type="ref"}. In this study, FASLG and LIMS1 were under the regulation of miR‐520c‐3p. It is found that treatment with miR‐520c will increase MMP‐9 expression, which regulates remodeling of the left ventricle after MI and is tightly linked to the inflammatory response [44](#feb412423-bib-0044){ref-type="ref"}.

It is reported that MAPK is a key signal pathway in MI [45](#feb412423-bib-0045){ref-type="ref"}. According to KEGG pathway enrichment analysis in MI, MAPK signal pathway was found covered the most DEGs, such as HSPA6 and MAPKAPK2. HSPA6 is found to be a regulated protein in planned MI patient samples [46](#feb412423-bib-0046){ref-type="ref"}. MAPKAPK2 is the substrate for p38‐MAPK and less abundant in failing heart [47](#feb412423-bib-0047){ref-type="ref"}, [48](#feb412423-bib-0048){ref-type="ref"}. In the present study, we found that HSPA6 and MAPKAPK2 were regulated by miR‐31\* and miR‐1291, respectively. It is worth mentioning that HSPA6 and miR‐31\* had a great diagnose value for MI. MiR‐1291 has been identified as a potential diagnosis biomarker for acute MI [49](#feb412423-bib-0049){ref-type="ref"}.

Clinically, HCM is defined in the presence of left ventricular hypertrophy in the absence of hypertension and valve disease. In this study, HCM was found to be the most enriched signal pathway, which involved several genes such as TPM3. TPM3 is found to be a regulated protein in planned MI patient samples [46](#feb412423-bib-0046){ref-type="ref"}. Herein, we found that TPM3 was regulated by miR‐139‐5p, and both miR‐139‐5p and TPM3 had a great diagnose value for MI. In human autopsy samples, miR‐139‐5p is down‐regulated earlier, within just 7 days following MI [11](#feb412423-bib-0011){ref-type="ref"}.

Beside miR‐27a, miR‐31\*, and miR‐139‐5p, we also found that miR‐204 and miR‐375 had the diagnose value for MI. MiR‐204 is an autophagy‐modulating miRNA that was related to cardiovascular disease [50](#feb412423-bib-0050){ref-type="ref"}. It is reported that the expression of miR‐375 is remarkably up‐regulated in heart tissue of MI and circulating miR‐375 is a potential diagnostic biomarker for MI [51](#feb412423-bib-0051){ref-type="ref"}, [52](#feb412423-bib-0052){ref-type="ref"}. In this study, we found both miR‐204 and miR‐375 had a great diagnose value for MI.

To analyze the expression of TFEB, IRS2, GRB2, FASLG, LIMS1, CX3CR1, HSPA6, TPM3, LAT2, CEBPD, AQP9, and MAPKAPK2 in the early stage of MI and further study the association between these genes with MI recovery, the datasets of <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE29532> and <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE48060> were used for analysis. Our results showed that all these genes were differentially expressed in different blood collection points. Moreover, these genes were associated with the recovery of MI. Therefore, we inferred that these genes may be considered as biomarkers for early stages of MI, as well as for monitoring early MI recovery.

In summary, we found several differentially expressed miRNA and genes in the blood of MI. MiR‐27a, miR‐31\*, miR‐1291, miR‐139‐5p, miR‐204, miR‐375, and target genes including CX3CR1, HSPA6, and TPM3 had a great diagnose value for MI. Additionally, MAPK and HCM were important signal pathways in the development of MI. TFEB, IRS2, GRB2, FASLG, LIMS1, CX3CR1, HSPA6, TPM3, LAT2, CEBPD, AQP9, and MAPKAPK2 may regard as biomarkers in MI early stage and recovery. Our study may be helpful in understanding the pathology mechanism of MI and could provide the clues in clinical diagnose and drug design of MI. There are limitations to our study. Firstly, sample size in the qRT‐PCR was small. Larger numbers of blood samples are needed for further research. Secondly, some animal models and cell culture experiments are needed to validate and explore the potential function of identified differentially expressed miRNA and genes in MI.
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